Akebia Therapeutics, Inc. (AKBA)
NASDAQ·Healthcare·Biotechnology
$0.47
+18.37%
Mkt Cap $111.20M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (4 analysts)
$1.00
Range $1.00 – $1.00
Implied Upside
+111.6%
Consensus $1.00 vs current $0.47
NASDAQ·Healthcare·Biotechnology
$0.47
+18.37%
Mkt Cap $111.20M
Buy
4
Hold
0
Sell
0
Price Target (4 analysts)
$1.00
Range $1.00 – $1.00
+111.6%
Consensus $1.00 vs current $0.47